tiprankstipranks
Trending News
More News >
Regeneron announces 24 abstract on Dupixent clinical data
PremiumThe FlyRegeneron announces 24 abstract on Dupixent clinical data
12d ago
Regeneron price target lowered to $810 from $940 at Guggenheim
Premium
The Fly
Regeneron price target lowered to $810 from $940 at Guggenheim
12d ago
Regeneron: Strong Growth Potential and Innovation Commitment Amidst Challenges
Premium
Ratings
Regeneron: Strong Growth Potential and Innovation Commitment Amidst Challenges
12d ago
Regeneron price target lowered to $800 from $865 at BMO Capital
PremiumThe FlyRegeneron price target lowered to $800 from $865 at BMO Capital
13d ago
Regeneron price target lowered to $700 from $750 at Wells Fargo
Premium
The Fly
Regeneron price target lowered to $700 from $750 at Wells Fargo
13d ago
Evan Seigerman’s Buy Rating on Regeneron: Overcoming Challenges with a Promising Pipeline and Undervalued Assets
Premium
Ratings
Evan Seigerman’s Buy Rating on Regeneron: Overcoming Challenges with a Promising Pipeline and Undervalued Assets
13d ago
Regeneron: Overcoming Challenges with Promising Growth Catalysts
PremiumRatingsRegeneron: Overcoming Challenges with Promising Growth Catalysts
14d ago
Regeneron price target lowered to $900 from $925 at Oppenheimer
Premium
The Fly
Regeneron price target lowered to $900 from $925 at Oppenheimer
14d ago
Regeneron reports Q1 adjusted EPS $8.22, consensus $8.48
Premium
The Fly
Regeneron reports Q1 adjusted EPS $8.22, consensus $8.48
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100